Structurally diverse low molecular weight activators of the mammalian pre-mRNA 3' cleavage reaction

Bioorg Med Chem. 2014 Jan 15;22(2):834-41. doi: 10.1016/j.bmc.2013.12.006. Epub 2013 Dec 15.

Abstract

The 3' end formation of mammalian pre-mRNA contributes to gene expression regulation by setting the downstream boundary of the 3' untranslated region, which in many genes carries regulatory sequences. A large number of protein cleavage factors participate in this pre-mRNA processing step, but chemical tools to manipulate this process are lacking. Guided by a hypothesis that a PPM1 family phosphatase negatively regulates the 3' cleavage reaction, we have found a variety of new small molecule activators of the in vitro reconstituted pre-mRNA 3' cleavage reaction. New activators include a cyclic peptide PPM1D inhibitor, a dipeptide with modifications common to histone tails, abscisic acid and an improved l-arginine β-naphthylamide analog. The minimal concentration required for in vitro cleavage has been improved from 200μM to the 200nM-100μM range. These compounds provide unexpected leads in the search for small molecule tools able to affect pre-mRNA 3' end formation.

Keywords: 3′ end formation; Histone code; Naphthalene ring; Polyadenylation; RNA; RNA processing; Small molecule activators.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Dose-Response Relationship, Drug
  • HeLa Cells
  • Humans
  • Molecular Structure
  • Molecular Weight
  • Peptides, Cyclic / pharmacology*
  • RNA 3' End Processing / drug effects*
  • Structure-Activity Relationship

Substances

  • Peptides, Cyclic